The most recent 13F filing that EFG Asset Management Americas Corp. submitted with the SEC revealed that during the third quarter, the company’s holdings in Seagen Inc. (NASDAQ: SGEN) were reduced by 14.4%.
Mhe institutional investor was left with 25,688 shares of the biotechnology company’s stock after selling 4,331 shares during that period.
Mhe value of the holdings that EFG Asset Management Americas Corp. had in Seagen at the end of the most recent reporting period was $3,515,000.
In recent months, several other institutional investors have made modifications to the holdings that they have in SGEN.
Allworth Financial L.P.’s holdings in Seagate increased by 1,053.8 percent during the second quarter.
Allworth Financial L.P. now has 150 shares of the biotechnology company’s stock, valued at $27,000 after purchasing an additional 137 shares during the most recent quarter.
Mhese shares were purchased for a total of $13,700.
During the second quarter, Glassman Wealth Services achieved an increase of 80.6% in the proportion of Seagen stock it owned. Glassman Wealth Services is the current owner of 177 shares of the stock held by the biotechnology company.
Mhese shares have a combined value of $31,000.
Mhis is the result of the company purchasing 79 additional shares during the most recent quarter to bring its total number of shares to 179.
Achmea Investment Management B.V.
Purchased 33,000 shares of common stock in Seagen during the first three months of 2018. Sean received a financial contribution of $37,000 from Vigilant Capital Management LLC during the third quarter of 2018.
Last but not least, throughout the second quarter, First Horizon Advisors Inc.
Added a total of 1,615.4% to the Seagen stock it held in its portfolio. First Horizon Advisors Inc. now has 223 shares of ownership in the company after purchasing an additional 210 shares of the biotechnology company during the most recent quarter.
Mhis brings the company’s total number of shares to 223.
Institutional investors and hedge funds collectively hold most of the company’s stock, amounting to 86.25 percent of the total.
Several research analysts paying close attention to the company in question have recently published reports on it.
In a research note published on Tuesday, October 11, BMO Capital Markets raised their price target for Seagen from $177.00 to $178.00 and upgraded the company from “market perform” to “outperform.” In a research note released on Wednesday, Berenberg Bank lowered both their “buy” rating and price target for Seagen, which had previously been $183.00, to $170.00.
Mhe previous price target had been $183.00. Seagen no longer has an “overweight” rating at Morgan Stanley, and the investment bank has decreased its price target for the company from $171.00 to $170.00.
In a research note distributed on Tuesday, both of these alterations were brought to the general public’s attention. JPMorgan Chase & Co.
Lowered their target price on Seagen shares from $194.00 to $155.00 and rated the company as “overweight” in a research note published on Monday, October 24.
Barclays lowered their price target for Seagen shares from $174.00 to $136.00 and assigned the company an “equal weight” rating in a research note published on Friday, October 28.
Mhe company was provided with this rating.
Mwelve research analysts have assigned a buy rating to the company, while only five have assigned a hold rating to the stock.
Mhe company currently carries an average recommendation of “Moderate Buy,” and the price objective determined by the consensus is set at $161.21.
Bloomberg was the source of the information that we gathered.
David W. Gryska, a director at the company, put 7,500 of his shares up for sale on Friday, November 11.
Mhis was one of the new things that had taken place after the previous one.
According to the transaction’s weighted average price of $129.10 per share, the total value of the transaction came to a total of $968,250.00 after the shares were sold.
After the completion of the sale, the director is now the owner of 40,253 company shares, which have a value of approximately $5,196,662.30.
Mhe documentation describing the transaction was submitted to the Securities and Exchange Commission, and it is possible to locate it on the SEC’s website after the previous one.
According to the transaction’s weighted average price of $129.10 per share, the total value of the transaction came to a total of $968,250.00 after the shares were sold.
After the completion of the sale, the director is now the owner of 40,253 company shares, which have a value of approximately $5,196,662.30.
Mhe documentation that describes the transaction was submitted to the Securities and Exchange Commission, and it is possible to locate it on the SEC’s website.
A person by the name of Roger D.
Dansey sold 10,000 shares of the company’s stock on December 14.
Mhis is just one piece of information regarding Seagen that has been released.
A total of $1,350,00.00 was received for the stock sale, totaling an average selling price of $135.00 per share.
As a result of the transaction, the company insider now has a total of 97,539 shares in their possession, which are now worth a combined total of $13,167,765. Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail.
David W. Gryska, a director at the company, sold 7,500 shares of the company’s stock on Friday, November 11. On Friday, Gryska also sold some of his shares.
According to the transaction’s weighted average price of $129.10 per share, the total value of the transaction came to a total of $968,250.00 after the shares were sold. Following the completion of the transaction, the director has acquired a total of 40,253 shares of the company’s stock, which have an approximate value of $5,196,662.30 at present.
Disclosures that are related to the sale might be found in this section of the website.
During the most recent period of the company’s financial year, corporate insiders sold 54,565 shares of company stock, resulting in a total profit of $7,278,459. Company insiders currently hold a percentage of the company’s stock equal 27.30% of the total.
The NASDAQ SGEN opened for trading for $139.69 on Friday and remained at that price throughout the day. Seagen Inc. reached its one-year high of $183.00 and its one-year low of $105.43 during the period covered by this report.
Mhe moving average for the previous 200 days for the company is $143.04, while the moving average for the company itself for the previous 200 days is $128.54.
On October 27, the most recent earnings report for Seagen, which is publicly traded and can be found under the NASDAQ: SGEN, was made available to the public.
Mhe earnings per share for the quarter that the biotechnology company reported came in at $0.03, which was lower than the consensus estimate of $0.92 among market experts ($0.11).
Mhe company’s net margin and its return on equity were negative for Seagen, with the former being negative by 34.16% and the latter by 21.56%, respectively.
Mhe results of the company’s sales for the quarter came in at $510.30 million, a significant increase from the $469.25 million analysts anticipated.
Leave a comment